NCT00361374View on ClinicalTrials.gov

Safety and Effectiveness of Omega 3-Fatty Acids, EPA Versus DHA, for the Treatment of Major Depression

PHASE3CompletedINTERVENTIONAL
Enrollment

196

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

February 28, 2013

Study Completion Date

March 31, 2013

Conditions
Major Depressive Disorder
Interventions
DIETARY_SUPPLEMENT

eicosapentaenoic acid

1 gram/day

DIETARY_SUPPLEMENT

docosahexaenoic acid

1 gram/day

DRUG

Placebo

980 milligram/day

Trial Locations (1)

02114

Depression Clinical Research Program, Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

Cedars-Sinai Medical Center

OTHER

collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Massachusetts General Hospital

OTHER

NCT00361374 - Safety and Effectiveness of Omega 3-Fatty Acids, EPA Versus DHA, for the Treatment of Major Depression | Biotech Hunter | Biotech Hunter